What Keros Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 6 |
| Sells | 4 | 12 |
| Total trades | 5 | 32 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 1,000 | 124,711 |
| Disposed | 9,828 | 789,690 |
| Net activity | −8,828 | −664,979 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Tanini Annita | Corp. Controller & VP, Finance | Aug 18 | Sale for tax withholding · S | −1,224 | $10.29 | −$12.6K | 45,144 |
| Newton Charles W. | Director | Aug 18 | Open-market sale · S | −551 | $10.30 | −$5.68K | 12,114 |
| Cho Esther | Chief Legal Officer | Aug 18 | Sale for tax withholding · S | −4,485 | $10.29 | −$46.2K | 35,770 |
| Lerner Lorena Raquel | Chief Scientific Officer | Aug 18 | Sale for tax withholding · S | −3,568 | $10.29 | −$36.7K | 27,559 |
| Bienaime Jean Jacques | Director | Aug 17 | Open-market buy · P | +1,000 | $10.27 | +$10.3K | 19,592 |
| Bienaime Jean Jacques | Director | Jul 15 | Open-market buy · P | +1,000 | $10.61 | +$10.6K | 18,592 |
| Prener Anne | Director | Jul 01 | Grant / award · A | +13,786 | — | — | 13,786 |
| Bienaime Jean Jacques | Director | Jun 15 | Open-market buy · P | +1,000 | $10.19 | +$10.2K | 17,592 |
| Newton Charles W. | Director | Jun 11 | Open-market sale · S | −550 | $10.04 | −$5.52K | 12,665 |
| Seth Alpna | Director | Jun 04 | Open-market sale · S | −2,625 | $10.72 | −$28.1K | 9,767 |
| Farzan Nima | Director | Jun 04 | Open-market sale · S | −2,625 | $10.73 | −$28.2K | 9,767 |
| Knowles Julius | Director | Jun 04 | Open-market sale · S | −2,625 | $10.73 | −$28.2K | 10,958 |
| Bienaime Jean Jacques | Director | Jun 03 | Grant / award · A | +7,142 | — | — | 16,592 |
| Gray Mary Ann | Director | Jun 03 | Grant / award · A | +7,142 | — | — | 12,392 |
| Seth Alpna | Director | Jun 03 | Grant / award · A | +7,142 | — | — | 12,392 |
| Knowles Julius | Director | Jun 03 | Grant / award · A | +7,142 | — | — | 13,583 |
| Farzan Nima | Director | Jun 03 | Grant / award · A | +7,142 | — | — | 12,392 |
| Bienaime Jean Jacques | Director | May 15 | Open-market buy · P | +1,000 | $10.58 | +$10.6K | 9,450 |
| Bienaime Jean Jacques | Director | Apr 15 | Open-market buy · P | +1,000 | $11.70 | +$11.7K | 8,450 |
| Seehra Jasbir | CHIEF EXECUTIVE OFFICER | Apr 02 | Exercise / conversion · M | +55,000 | $0.30 | +$16.5K | 440,708 |
Loading...
